Clinical trial Recruiting at 13 sites Interventional Ages 18 to 65

Mindfulness Intervention for Emotional Distress in GERD

Official title: Effects of an Online Mindfulness-Based Emotion Intervention on Symptoms and Emotional Distress in Patients With Gastroesophageal Reflux Disease: A Multicenter Randomized Waitlist-Controlled Trial

Run by Peking University · NCT07667894 · Data updated 2026-11-12

This online mindfulness program is being tested to see if it can help adults with GERD feel less emotional distress and experience fewer reflux symptoms.

Quick facts

Study typeInterventional
Ages18 Years to 65 Years
SexAll
Enrollment500 (estimated)
SponsorPeking University
Academic / other
Locations15 sites (Beijing, Beijing Municipality and 14 other locations)
StatusRecruiting
StartedJune 29, 2026
Main results expectedMay 15, 2028
Study endsMay 15, 2028
Registry record updatedOctober 7, 2026
Trial IDNCT07667894 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults 18–65 with GERD and a GERD-Q score of 8 or higher who can participate in an online program and maintain their usual treatment.

Probably not a fit

Participants without significant distress reduction or symptom improvement may not benefit from the intervention.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This multicenter randomized trial compares online Mindfulness-Based Intervention for Emotional Distress (MIED) against a waitlist control in adults with GERD. Participants will complete online assessments and engage in a mindfulness course while maintaining their usual treatment unless medically required changes. The study looks at changes in emotional distress, reflux-related symptoms, and quality of life, as well as related psychological processes. It uses a waitlist design to determine whether MIED provides benefits beyond standard care. Enrollment targets adults aged 18–65 with GERD symptoms and internet access.

Why it matters

Potential benefit: If successful, participants may experience reduced emotional distress and improved GERD-related symptoms and quality of life.

How similar studies have gone: Online mindfulness programs have shown potential benefits for emotional distress and some gastrointestinal symptoms in related populations, but results vary by condition and setting.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria

Participants must meet all of the following criteria:

1. Aged 18 to 65 years.
2. GERD-Q score of 8 or higher.
3. Willingness to maintain a relatively stable usual treatment regimen during the study unless medically indicated changes are required.
4. Ability to use a smartphone, computer, or tablet to participate in the online program and complete online questionnaires.
5. Willingness to comply with course training and follow-up assessments.
6. Ability to understand the study and provide written or electronic informed consent.

Exclusion Criteria

Participants meeting any of the following criteria will be excluded:

1. Alarm symptoms or high suspicion of serious organic disease, including but not limited to progressive dysphagia, hematemesis, melena, unexplained weight loss, anemia, recurrent vomiting, or persistent chest pain without exclusion of cardiovascular risk.
2. Current or previous severe esophageal organic disease or gastrointestinal malignancy.
3. History of anti-reflux surgery, partial gastrectomy, or other upper gastrointestinal surgery that may substantially affect reflux symptom assessment.
4. GERD-Q score greater than 15, or symptoms judged by the study physician to be extremely severe and requiring priority medical evaluation or intensified treatment.
5. Current uncontrolled severe mental disorder, such as schizophrenia, manic episode of bipolar disorder, acute severe depressive episode, or severe substance use disorder.
6. Current suicide risk, operationalized as a score greater than 1 on item 9 of the PHQ-9.
7. Previous systematic participation in MIED, mindfulness-based stress reduction, mindfulness-based cognitive therapy, or another structured mindfulness program.

Where it's running

  • Being Haidian Hospital
    Beijing, Beijing Municipality, China
    Recruiting
  • PLA Rocket Force Characteristic Medical Center
    Beijing, Beijing Municipality, China
    Recruiting
  • Peking University
    Beijing, Beijing Municipality, China
    Recruiting
  • Baiyin Central Hospital
    Baiyin, Gansu, China
    Recruiting
  • Peking University Shenzhen Hospital
    Shenzhen, Guangdong, China
    Recruiting
  • Center Hospital Qinghe County
    Xingtai, Hebei, China
    Recruiting
Show 9 more locations
  • Xinle City Hospital
    Xinle, Hebei, China
    Recruiting
  • Affiliated Houspital of Chifeng University
    Chifeng, Inner Mongolia, China
    Recruiting
  • Xilingol League Mongolian Medicine Hospital
    Hohhot, Inner Mongolia, China
    Recruiting
  • The First Affiliated Hospital of Nanjing Medical University
    Nanjing, Jiangsu, China
    Recruiting
  • Shandong Second Provincial General Hospital
    Jinan, Shandong, China
    Recruiting
  • the Second People's Hospital of Liaocheng
    Liaocheng, Shandong, China
    Recruiting
  • Shanghai sixth people's hospital
    Shanghai, Shanghai Municipality, China
    Recruiting
  • the first affiliated hospital of GuiZhou medical university
    Guiyang, Guizhou, China
    Not yet recruiting
  • Changzhi People'S Hospital
    Changzhi, Shanxi, China
    Not yet recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.